Anuradha Dube Selected Research

Anuradha Dube Research Topics

Disease

59	Visceral Leishmaniasis (Kala Azar) 02/2023 - 11/2004
16	Infections 01/2021 - 11/2004
15	Leishmaniasis 01/2021 - 12/2004
4	Hypersensitivity (Allergy) 01/2017 - 10/2008
3	Parasitic Diseases (Parasitic Disease) 02/2023 - 01/2019
3	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2013
2	Hemolysis 12/2017 - 12/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2022
1	Disease Progression 01/2021
1	Malnutrition (Nutritional Deficiencies) 08/2020
1	Body Weight (Weight, Body) 03/2020
1	Coinfection 08/2015
1	Reinfection 01/2014
1	Leprosy (Hansen's Disease) 04/2013
1	Tuberculosis (Tuberculoses) 04/2013
1	Pulmonary Tuberculosis 04/2013
1	Mycoses (Diseases, Fungus) 03/2012
1	Necrosis 02/2012
1	Cutaneous Leishmaniasis 04/2009

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 05/2022 - 03/2006
15	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2017 - 07/2007
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2006
6	AntigensIBA 01/2021 - 03/2006
6	ChitosanIBA 12/2017 - 01/2011
5	CytokinesIBA 01/2021 - 02/2012
5	NanocapsulesIBA 08/2015 - 11/2012
5	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2015 - 01/2011
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 10/2005
4	Interleukin-12 (IL 12)IBA 02/2012 - 10/2008
3	Interleukin-4 (Interleukin 4)IBA 01/2021 - 01/2012
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2012
3	LipidsIBA 03/2012 - 07/2007
3	Immunoglobulin G (IgG)IBA 01/2012 - 10/2008
2	EnzymesIBA 05/2022 - 01/2014
2	InterferonsIBA 01/2019 - 02/2012
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2017 - 02/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 01/2005
2	LigandsIBA 12/2015 - 11/2012
2	AntimonyIBA 08/2015 - 04/2009
2	SodiumIBA 08/2015 - 04/2009
2	gluconic acid (gluconate)FDA LinkGeneric 08/2015 - 04/2009
2	NAD (NADH)IBA 04/2015 - 03/2015
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 10/2014 - 04/2013
2	GelatinIBA 05/2014 - 02/2010
2	Protein Disulfide-IsomerasesIBA 01/2014 - 01/2012
2	Liposomes (Liposome)IBA 03/2012 - 03/2006
1	liposomal amphotericin B FDA Link 02/2023
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 02/2023
1	Adenosine Triphosphate (ATP)IBA 05/2022
1	Purinergic P2X7 ReceptorsIBA 05/2022
1	Interleukin-13IBA 01/2021
1	Linoleic Acid (Linoleate)IBA 08/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2020
1	Glucose (Dextrose)FDA LinkGeneric 03/2020
1	Uric Acid (Urate)IBA 03/2020
1	Alkaline PhosphataseIBA 03/2020
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	EicosanoidsIBA 01/2020
1	Vaccine AdjuvantsIBA 12/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	InterleukinsIBA 01/2019
1	SuspensionsIBA 12/2017
1	MicellesIBA 12/2017
1	Polysorbates (PSML)FDA Link 12/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	calcium phosphateIBA 11/2016
1	GalactosamineIBA 12/2015
1	ChondroitinIBA 08/2015
1	Mannose (D-Mannose)IBA 08/2015
1	glycol-chitosanIBA 05/2015
1	StearatesIBA 05/2015
1	AlginatesIBA 05/2015
1	lipoteichoic acidIBA 04/2015
1	ChaperoninsIBA 04/2015
1	tryparedoxin peroxidaseIBA 04/2015
1	LactoferrinIBA 01/2015
1	Lipid NanoparticlesIBA 10/2014
1	Mitogen Receptors (Mitogen Receptor)IBA 06/2014
1	LectinsIBA 06/2014
1	trypanothione reductaseIBA 03/2014
1	IsomerasesIBA 01/2014
1	Phosphates (Orthophosphate)IBA 01/2014
1	Mycobacterium w vaccineIBA 04/2013
1	Immunologic Factors (Immunomodulators)IBA 04/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	PhosphatidylserinesIBA 11/2012
1	Methionine (L-Methionine)FDA Link 05/2012
1	AminopeptidasesIBA 05/2012
1	tripalmitinIBA 03/2012
1	miltefosine (Impavido)IBA 02/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2012
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 01/2012
1	MannansIBA 02/2011
1	1,4-dihydropyridine (dihydropyridine)IBA 07/2010
1	DNA (Deoxyribonucleic Acid)IBA 07/2009
1	DNA VaccinesIBA 07/2009

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2021 - 11/2004
9	Therapeutics 02/2023 - 12/2004
3	Immunotherapy 01/2021 - 10/2014